Biocon Rises After Starting Manufacture of Lipitor Ingredients

Biocon Ltd. (BIOS), the nation’s biggest biotechnology company, climbed in Mumbai trading after Chairman Kiran Mazumdar-Shaw said the drugmaker has begun manufacturing ingredients for Pfizer Inc. (PFE)’s Lipitor cholesterol medicine. The company expects its Malaysia plant to be fully operational by early 2014, Mazumdar-Shaw said.

The stock rose 1.1 percent to 330 rupees as of 9:16 a.m. local time.

To contact the editor responsible for this story: Suresh Seshadri at sseshadri1@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.